ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 55,001 shares, the number of shares held decreased 7.83% compared to the previous period and now represents 2.73% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 186,762 shares, the number of shares held decreased 16.34% compared to the previous period and now represents 4.94% of the total position.
ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 42 shares, the number of shares held increased 0.34% compared to the previous period and now represents 0.71% of the total position.
ARKG Investment Tracker position change: Increased position in Incyte by 534 shares, the number of shares held increased 0.36% compared to the previous period and now represents 1.21% of the total position.
ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 4,050 shares, the number of shares held increased 0.36% compared to the previous period and now represents 5.28% of the total position.
ARKG Investment Tracker position change: Increased position in Natera by 1,173 shares, the number of shares held increased 0.36% compared to the previous period and now represents 4.73% of the total position.
ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 10,257 shares, the number of shares held increased 0.36% compared to the previous period and now represents 3.41% of the total position.
ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 5,472 shares, the number of shares held increased 0.36% compared to the previous period and now represents 1.67% of the total position.
ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 7,212 shares, the number of shares held increased 0.36% compared to the previous period and now represents 3.86% of the total position.